Clinical trial

A Study of the Safety of Topiramate Given in Combination With Other Medications…

NCT00297349 · Janssen Cilag Pharmaceutica S.A.C.I., Greece, Industry · Completed

Key facts

NCT number NCT00297349
Title A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures
Official title An Open-label Observation Study of Topiramate Administration as Adjuvant Therapy for Focal Epilepsy, Lennox-Gastaut Syndrome Epileptic Seizures and Generalized Tonoclonic Seizures in Adults and Children Aged 2 Years and Older
Lead sponsor Janssen Cilag Pharmaceutica S.A.C.I., Greece, Industry
Status Completed
Study type Observational
Conditions Seizures, Epilepsy
Intervention type Drug
Interventions Topiramate
Enrollment 153
Start date Nov 1, 2003
Completion Jun 1, 2005
First posted Feb 28, 2006
Last update posted Apr 27, 2010

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies